@abdelhamid012.bsky.social
Reposted
👀 WATCH NOW: Joel Topf @kidneyboy.bsky.social caught up with Rajiv Agarwal at #KidneyWk in Houston, where the latter presented CONFIDENCE findings on implementation of finerenone and empagliflozin. #nephrology #nephsky #kidneydisease #hyperkalemia #sglt2 www.docwirenews.com/post/hyperka...
Hyperkalemia With Empagliflozin and Finerenone | Docwire News
Joel Topf, MD, interviewed Rajiv Agarwal, MBBS, about an implementation analysis of CONFIDENCE findings on hyperkalemia with finerenone and empagliflozin in chronic kidney disease.
www.docwirenews.com
November 21, 2025 at 2:52 PM
👀 WATCH NOW: Joel Topf @kidneyboy.bsky.social caught up with Rajiv Agarwal at #KidneyWk in Houston, where the latter presented CONFIDENCE findings on implementation of finerenone and empagliflozin. #nephrology #nephsky #kidneydisease #hyperkalemia #sglt2 www.docwirenews.com/post/hyperka...
Reposted
Is It Time to Consider Population-Based Urine Dipstick Screening for Early Detection of Kidney Disease? ca. 2025 from @kireports.bsky.social @saynanorouzi.bsky.social
#Nephpearls #KidneyWk #NephSky
👉 www.kireports.org/article/S246...
#Nephpearls #KidneyWk #NephSky
👉 www.kireports.org/article/S246...
November 7, 2025 at 2:58 PM
Is It Time to Consider Population-Based Urine Dipstick Screening for Early Detection of Kidney Disease? ca. 2025 from @kireports.bsky.social @saynanorouzi.bsky.social
#Nephpearls #KidneyWk #NephSky
👉 www.kireports.org/article/S246...
#Nephpearls #KidneyWk #NephSky
👉 www.kireports.org/article/S246...
Reposted
Ischemia-reperfusion injury (IRI) is an unavoidable consequence of kidney transplantation, can targeting complement activated via the lectin and alternative pathways help reduce IRI and its clinical impact? Read more in this #ASNJASN #Review kidney.pub/JASN0826
August 29, 2025 at 4:00 PM
Ischemia-reperfusion injury (IRI) is an unavoidable consequence of kidney transplantation, can targeting complement activated via the lectin and alternative pathways help reduce IRI and its clinical impact? Read more in this #ASNJASN #Review kidney.pub/JASN0826
Reposted
2025 Concise Clinical Guidance:
An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health
by Drs. Gilbert, @drmarthagulati.bsky.social, Gluckman, @mkittlesonmd.bsky.social, Rikhi, Saseen, Tchang
An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health
by Drs. Gilbert, @drmarthagulati.bsky.social, Gluckman, @mkittlesonmd.bsky.social, Rikhi, Saseen, Tchang
August 12, 2025 at 7:11 PM
2025 Concise Clinical Guidance:
An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health
by Drs. Gilbert, @drmarthagulati.bsky.social, Gluckman, @mkittlesonmd.bsky.social, Rikhi, Saseen, Tchang
An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health
by Drs. Gilbert, @drmarthagulati.bsky.social, Gluckman, @mkittlesonmd.bsky.social, Rikhi, Saseen, Tchang
Reposted
What are the best practices for treating patients receiving peritoneal dialysis while hospitalized? This #ASNCJASN "Kidney Case Conference: How I Treat" shares clinician perspective on protocol and procedure. kidney.pub/CJASN0783
July 18, 2025 at 1:00 PM
What are the best practices for treating patients receiving peritoneal dialysis while hospitalized? This #ASNCJASN "Kidney Case Conference: How I Treat" shares clinician perspective on protocol and procedure. kidney.pub/CJASN0783
Reposted
Effect of losartan on endothelial function in women with history of #preeclampsia
🔗 academic.oup.com/ajh/article/... 🔓
#OpenAccess #Free
🔗 academic.oup.com/ajh/article/... 🔓
#OpenAccess #Free
July 14, 2025 at 8:34 AM
Effect of losartan on endothelial function in women with history of #preeclampsia
🔗 academic.oup.com/ajh/article/... 🔓
#OpenAccess #Free
🔗 academic.oup.com/ajh/article/... 🔓
#OpenAccess #Free
Reposted
Join us for this Global Renal Exercise Group (GREX) Webinar about intradialytic exercise on July 17th. Free registration at: us06web.zoom.us/webinar/regi...
June 26, 2025 at 1:53 PM
Join us for this Global Renal Exercise Group (GREX) Webinar about intradialytic exercise on July 17th. Free registration at: us06web.zoom.us/webinar/regi...
Reposted
CHECK OUT our interview with Dr. George Edward Newman, a PI for the #PREVAIL trial of #felzartamab for #IgAN. His Knoxville site recently dosed its first patient. #nephrology #nephsky #iganephropathy www.docwirenews.com/post/prevail...
PREVAIL Investigator on Felzartamab’s Potential to Change IgAN Therapy | Docwire News
Dr. George Newman of Knoxville Kidney Center discussed the PREVAIL study of felzartamab for IgA nephropathy (IgAN). Dr. Newman is a site PI for the trial.
www.docwirenews.com
June 26, 2025 at 4:57 PM
CHECK OUT our interview with Dr. George Edward Newman, a PI for the #PREVAIL trial of #felzartamab for #IgAN. His Knoxville site recently dosed its first patient. #nephrology #nephsky #iganephropathy www.docwirenews.com/post/prevail...
Reposted
Tirzepatide associated with 1ml/min/yr slower decline in eGfR crcys and decreased albuminuria (30% in those with baseline albuminuria, less for those with normoalbuminuria)! #ada2025
June 20, 2025 at 11:20 PM
Tirzepatide associated with 1ml/min/yr slower decline in eGfR crcys and decreased albuminuria (30% in those with baseline albuminuria, less for those with normoalbuminuria)! #ada2025
Reposted
Some conclusions from a great talk on monoclonal gammopathies of renal significance from Dr. Nasr at @glomcon.org today:
May 25, 2025 at 4:14 PM
Some conclusions from a great talk on monoclonal gammopathies of renal significance from Dr. Nasr at @glomcon.org today:
Reposted
More on BEDMED:
youtu.be/mqkTYElw0fo?...
With @rickyturgeon.bsky.social Dr. Scott Garrison @hswapnil.medsky.social and Dr. Isla Mackenzie
@markusathome.bsky.social
youtu.be/mqkTYElw0fo?...
With @rickyturgeon.bsky.social Dr. Scott Garrison @hswapnil.medsky.social and Dr. Isla Mackenzie
@markusathome.bsky.social
May 16, 2025 at 6:02 AM
More on BEDMED:
youtu.be/mqkTYElw0fo?...
With @rickyturgeon.bsky.social Dr. Scott Garrison @hswapnil.medsky.social and Dr. Isla Mackenzie
@markusathome.bsky.social
youtu.be/mqkTYElw0fo?...
With @rickyturgeon.bsky.social Dr. Scott Garrison @hswapnil.medsky.social and Dr. Isla Mackenzie
@markusathome.bsky.social
Reposted
𝗜𝗦𝗡 𝗩𝗜𝗗𝗘𝗢 𝗔𝗕𝗦𝗧𝗥𝗔𝗖𝗧 𝗦𝗘𝗥𝗜𝗘𝗦: The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial. 2025 from @kidneyint.bsky.social www.kidney-internati...
#VideoAbstract by @drsumanbehera.bsky.social
#VideoAbstract by @drsumanbehera.bsky.social
May 16, 2025 at 12:00 PM
𝗜𝗦𝗡 𝗩𝗜𝗗𝗘𝗢 𝗔𝗕𝗦𝗧𝗥𝗔𝗖𝗧 𝗦𝗘𝗥𝗜𝗘𝗦: The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial. 2025 from @kidneyint.bsky.social www.kidney-internati...
#VideoAbstract by @drsumanbehera.bsky.social
#VideoAbstract by @drsumanbehera.bsky.social
Reposted
Complement activation in secondary thrombotic microangiopathies
doi.org/10.1093/ndt/...
👉This review summarizes the current understanding and future directions in the management of secondary TMA, emphasizing the potential of complement inhibition as therapeutic strategy
doi.org/10.1093/ndt/...
👉This review summarizes the current understanding and future directions in the management of secondary TMA, emphasizing the potential of complement inhibition as therapeutic strategy
May 15, 2025 at 7:18 PM
Complement activation in secondary thrombotic microangiopathies
doi.org/10.1093/ndt/...
👉This review summarizes the current understanding and future directions in the management of secondary TMA, emphasizing the potential of complement inhibition as therapeutic strategy
doi.org/10.1093/ndt/...
👉This review summarizes the current understanding and future directions in the management of secondary TMA, emphasizing the potential of complement inhibition as therapeutic strategy
Reposted
Interesting case report in @ajkd.bsky.social
Osmotic nephropathy from fenofibrate (or its excipient?)
www.ajkd.org/article/S027...
#NephSky
If true, add to contrast, dextran/starch, mannitol, flozins (pubmed.ncbi.nlm.nih.gov/32387022/)
Osmotic nephropathy from fenofibrate (or its excipient?)
www.ajkd.org/article/S027...
#NephSky
If true, add to contrast, dextran/starch, mannitol, flozins (pubmed.ncbi.nlm.nih.gov/32387022/)
May 12, 2025 at 10:26 PM
Interesting case report in @ajkd.bsky.social
Osmotic nephropathy from fenofibrate (or its excipient?)
www.ajkd.org/article/S027...
#NephSky
If true, add to contrast, dextran/starch, mannitol, flozins (pubmed.ncbi.nlm.nih.gov/32387022/)
Osmotic nephropathy from fenofibrate (or its excipient?)
www.ajkd.org/article/S027...
#NephSky
If true, add to contrast, dextran/starch, mannitol, flozins (pubmed.ncbi.nlm.nih.gov/32387022/)
Reposted
Dapagliflozin in non-diabetic CKD with low/high ACR - OPTIMISE CKD observational design
Pretty flat GFR slopes?
academic.oup.com/ckj/article/... on @ckj-era.bsky.social
#NephSky #OpenAccess
Pretty flat GFR slopes?
academic.oup.com/ckj/article/... on @ckj-era.bsky.social
#NephSky #OpenAccess
May 10, 2025 at 9:17 PM
Dapagliflozin in non-diabetic CKD with low/high ACR - OPTIMISE CKD observational design
Pretty flat GFR slopes?
academic.oup.com/ckj/article/... on @ckj-era.bsky.social
#NephSky #OpenAccess
Pretty flat GFR slopes?
academic.oup.com/ckj/article/... on @ckj-era.bsky.social
#NephSky #OpenAccess
Lupus nephritis and during pregnancy treatments
January 13, 2025 at 3:22 PM
Lupus nephritis and during pregnancy treatments
Reposted
⬇️C3/C4 in kidney dz not a coincidence, it’s about injury to the endothelium:
1. SLE III-IV: subendothelial IC (sEnIC), endocapillary prolif (EnCP)
2. IRGN (bact): EnCP, +/- sEnIC
3. MPGN (viral, idiop): EnCP, sEnIC
4. TMA: compl-endothel injury
5. Atheroemboli: chol cryst-endothel injury
#Nephsky
1. SLE III-IV: subendothelial IC (sEnIC), endocapillary prolif (EnCP)
2. IRGN (bact): EnCP, +/- sEnIC
3. MPGN (viral, idiop): EnCP, sEnIC
4. TMA: compl-endothel injury
5. Atheroemboli: chol cryst-endothel injury
#Nephsky
Hypocomplementemia in glomerulonephritis: Testing for "complement activation" is an essential early step in the evaluation of glomerular disease
#Nephpearls #NephSky
👉 shop.lww.com/Handbook-of-...
#Nephpearls #NephSky
👉 shop.lww.com/Handbook-of-...
January 12, 2025 at 1:59 AM
⬇️C3/C4 in kidney dz not a coincidence, it’s about injury to the endothelium:
1. SLE III-IV: subendothelial IC (sEnIC), endocapillary prolif (EnCP)
2. IRGN (bact): EnCP, +/- sEnIC
3. MPGN (viral, idiop): EnCP, sEnIC
4. TMA: compl-endothel injury
5. Atheroemboli: chol cryst-endothel injury
#Nephsky
1. SLE III-IV: subendothelial IC (sEnIC), endocapillary prolif (EnCP)
2. IRGN (bact): EnCP, +/- sEnIC
3. MPGN (viral, idiop): EnCP, sEnIC
4. TMA: compl-endothel injury
5. Atheroemboli: chol cryst-endothel injury
#Nephsky
January 11, 2025 at 9:36 AM
Guidelines should protect patients from non expert But experts should protect patients from guidelines
January 11, 2025 at 8:18 AM
Guidelines should protect patients from non expert But experts should protect patients from guidelines
